Article citationsMore>>

Collier, K.A., Valencia, H., Newton, H., et al. (2021) A Phase 1 Trial of the Histone Deacetylase Inhibitor AR-42 in Patients with Neurofibromatosis Type 2-Associated Tumors and Advanced Solid Malignancies. Cancer Chemotherapy and Pharmacology, 87, 599-611.
https://doi.org/10.1007/s00280-020-04229-3

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top